Semaglutide is the active ingredient in Wegovy, approved for chronic weight management, and Ozempic, approved for type 2 diabetes.
Bergen County budgets and employer plans
Our New Jersey figures come from Bergen County, the county we use as the state anchor. Its median household income was $124,884 in 2020 to 2024 [2]. Two $199 starter fills followed by ten months at $349 total $3,888 for a first year of pens [1], close to 3% of that median. For many Bergen households the harder question is coverage, not cash: Lilly points to an IFEBP survey finding that roughly half of workers with employer insurance have no obesity drug benefit [5].
Sponsored placement: open.
One local practice can be featured here. This is a paid, labeled placement and never an endorsement.
Feature your practice in New Jersey, from $300 a month.
Advertisers pay for this labeled slot; paying buys no endorsement from us.
Ask your plan before you pay cash
- Look up Wegovy, pen and pill, on your plan's formulary.
- If the plan covers it, Novo's savings offer can bring the copay down to $25, with up to $100 a month in savings [1].
- If it does not, the pen's self-pay price is $349, the 7.2 mg Wegovy HD pen is $399, and the tablet runs $149 at 1.5 mg, $199 at 4 mg and $299 at 9 or 25 mg [1]. Ozempic, the type 2 diabetes brand, is $349, or $499 at 2 mg [6].
- On Medicare Part D, ask about the GLP-1 Bridge, which charges $50 a month to people who qualify [7].
More detail: semaglutide cost, Wegovy cost and Wegovy insurance coverage.
The evidence in two sentences
Adults in STEP 1 who took semaglutide 2.4 mg lost 14.9% of body weight on average by week 68, compared with 2.4% on placebo [8], and an extension found about two-thirds of the loss returned within a year off the drug [9]. Wegovy is also approved to lower the chance of a heart attack, a stroke or cardiovascular death for adults who live with both heart disease and excess weight [10]; see semaglutide results.
Compounded and salt-form semaglutide in New Jersey
FDA's grace period for pharmacies compounding semaglutide ended in April 2025 [11]. A compounded version has no FDA approval. Nor does FDA check its effectiveness, safety or quality. The agency also says salt forms such as semaglutide sodium are different active ingredients from the approved drugs, with no lawful basis it knows of for compounding them [12]. The State Board of Medical Examiners handles physician licensing in New Jersey [13]; read compounded semaglutide.
Label warnings
Rodent studies tied semaglutide to thyroid C-cell tumors, which is why Wegovy carries a boxed warning; skip it if you or a close relative ever had MTC, or if you have MEN 2. Stomach pain that is intense and will not ease may be pancreatitis. Watch for allergic reactions, and for low blood sugar if you also use insulin or a sulfonylurea. If you hope to conceive, the label wants semaglutide stopped 2 months or more beforehand [10]. For an emergency, dial 911.
Nearby semaglutide pages
Across the Hudson: semaglutide in New York City and Long Island. Farther west, semaglutide in Pittsburgh covers Pennsylvania, whose Medicaid program dropped obesity coverage on January 1, 2026 [14]; to the south, see Baltimore. Also: finding semaglutide near you, online semaglutide and the semaglutide guide.
Questions people ask
What does semaglutide cost in New Jersey without insurance?
NovoCare charged $349 a month for the Wegovy pen and $149 to $299 for the tablet on October 17, 2026 [1].
Does New Jersey Medicaid pay for Wegovy for weight loss?
Not for obesity, as far as KFF's count shows: its January 2026 tally of 13 state programs paying for these drugs leaves New Jersey out [4].
How common is obesity in Bergen County?
CDC PLACES estimates that 25.6% of Bergen County adults had obesity in 2023 and 9.7% had diagnosed diabetes [3].
How much is a first year of Wegovy pens in New Jersey?
About $3,888: two $199 starter fills, then ten months at $349, using NovoCare prices from October 17, 2026 [1].
Who licenses New Jersey physicians?
The New Jersey State Board of Medical Examiners, within the Division of Consumer Affairs [13].
Is semaglutide sodium the same as Wegovy?
No. FDA treats semaglutide sodium and semaglutide acetate as active ingredients distinct from approved semaglutide and says it knows of no lawful basis to compound with them [12].
Sources
14 cited
- Wegovy self-pay offer. Novo Nordisk (NovoCare), accessed 2026-10-17.
- QuickFacts: Bergen County, New Jersey. U.S. Census Bureau, V2025 estimates, accessed 2026-10-17.
- PLACES county estimates: Bergen County, NJ. CDC PLACES (2025 release, BRFSS 2023), 2025 release.
- Medicaid coverage of and spending on GLP-1s. KFF, Jan 16, 2026.
- Foundayo launch release (citing IFEBP survey). Eli Lilly and Company, Apr 9, 2026.
- Ozempic self-pay pricing. Novo Nordisk (NovoCare), accessed 2026-10-17.
- Weight loss drugs coverage. Medicare.gov, accessed 2026-10-17.
- Once-weekly semaglutide in adults with overweight or obesity (STEP 1). New England Journal of Medicine (PubMed), Feb 10, 2021.
- Weight regain after withdrawal of semaglutide (STEP 1 extension). Diabetes, Obesity and Metabolism (PubMed), May 19, 2022.
- Wegovy label. DailyMed, NLM, Jun 2026.
- FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize. U.S. Food and Drug Administration, Apr 1, 2026.
- FDA's concerns with unapproved GLP-1 drugs used for weight loss. U.S. Food and Drug Administration, Oct 1, 2026.
- State Board of Medical Examiners. New Jersey Division of Consumer Affairs, accessed 2026-10-17.
- Medical Assistance Bulletin: GLP-1 coverage for weight loss. Pennsylvania Department of Human Services, Nov 24, 2025.
This page is general information, not medical advice. Talk with a licensed clinician about your own care.